.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Covington
Mallinckrodt
US Department of Justice
Citi
Colorcon
Chinese Patent Office
US Army
Deloitte

Generated: December 17, 2017

DrugPatentWatch Database Preview

PRILOCAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Prilocaine Hydrochloride, and what generic alternatives are available?

Prilocaine Hydrochloride is a drug marketed by Septodont Inc and is included in two NDAs.

The generic ingredient in PRILOCAINE HYDROCHLORIDE is epinephrine bitartrate; prilocaine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
Drug patent expirations by year for PRILOCAINE HYDROCHLORIDE

Pharmacology for PRILOCAINE HYDROCHLORIDE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont IncPRILOCAINE HYDROCHLORIDEprilocaine hydrochlorideINJECTABLE;INJECTION079235-001Sep 29, 2010RXNoYes► Subscribe► Subscribe► Subscribe
Septodont IncPRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATEepinephrine bitartrate; prilocaine hydrochlorideINJECTABLE;INJECTION078959-001Aug 30, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Deloitte
Mallinckrodt
Cantor Fitzgerald
Chubb
Healthtrust
Accenture
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot